Modafinil: The European experience

Narcolepsy and Hypersomnia

Volumn , Issue , 2006, Pages 561-570

  Billiard, Michel ^a   Nicolet, Agnes ^b   Dauvilliers, Yves ^a   Carlander, Bertrand ^a  

^a GUI DE CHAULIAC HOSPITAL   (France)

^b Department of Pharmaceutical Chemistry   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77953638558     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (30)

1. Goldenberg F, Weil JS, Von Frenckeel. Effects of modafinil on diurnal variation of objective sleepiness in normal subjects. Sleep Res 1987; 16:91.
2. Saletu B, Frey R, Krupka M, Anderer P, Grunberger J, Barbanoj MJ. Differential effects of a new central adrenergic agonist modafinil and d-amphetamine on sleep and early morning behaviour in young healthy volunteers. Int J Clin Pharm Res 1989; 9:183-195.
3. Brun J, Chamba G, Khalfallah Y, Girard P, Boissy I, Bastuji, Sassolas G, Claustrat B. Effects of modafinil on plasm melatonin, cortisol and growth hormone rhythms, rectal temperature and performance in healthy subjects during a 36 hour sleep deprivation. J Sleep Res 1998; 7:105-114
4. Turner DC, Robbins TW, Clark L, Aron AR, Dowson J, Sahakian BJ. Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology (Berl) 2003; 165:260-269.
5. Randall DC, Shneerson JM, Plaha KK, File SE. Modafinil affects mood, but not cognitive function, in healthy young volunteers. Hum Psychopharmacol 2003; 18:163-173.
6. Saletu B, Saletu M, Grunberger J, Frey R, Zatschek I, Mader R. On the treatment of the alcoholic organic brain syndrome with an alpha-adrenergic agonist modafinil: double-blind, placebo-controlled clinical, psychometric and neurophysiological studies. Prog Neuropsychopharmacol Biol Psychiatry 1990; 14:195-214.
7. Saletu B, Saletu M, Grunberger J, Frey R, Andere P, Mader R. Treatment of the alcoholic organic brain syndrome: double-blind, placebo-controlled clinical, psychometric and electroencephalographic mapping studies with modafinil. Neuropsychobiology 1993; 27:26-39.
8. Lagarde D, Batejat D, Van Beers P, Sarafian D, Pradella S. Interest of modafinil, a new psychostimulant, during a sixty-hour sleep deprivation experiment. Fundam Clin Pharmacol 1995; 9:271-279.
9. Batejat DM, Lagarde DP. Naps and modafinil as countermeasures for the effects of sleep deprivation on cognitive performance. Aviat Space Environ Med 1999; 70:493-498.
10. Buguet A, Montmayeur A, Pigeau R, Naitoh P. Modafinil, d-amphetamine and placebo during 64-hours of sustained mental work. II. Effects on two nights of recovery sleep.
11. Buguet A, Moroz DE, Radomski MW. Modafinil-medical considerations for use in sustained operations. Aviat Space Environ Med 2003; 74:659-663.
12. Arnulf I, Homeyer P, Garma L, Whitelaw WA, Derenne JP. Modafinil in obstructive sleep apnea-hypopnea syndrome: a pilot study in 6 patients. Respiration, 1997; 64:159-161.
13. Kingshott RN, Vennelle M, Coleman EL, Engleman HM, Mackay TW, Douglas NJ. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of residual excessive daytime sleepiness in the sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 2001; 163:918-923.
14. Zifko UA, Rupp M, Schwarz S, Zipko HT, Maida EM. Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study. J Neurol 2002; 249:983-987.
15. Zifko UA. Management of fatigue in patients with multiple sclerosis. Drugs 2004; 64:1295-1304.
16. Montastruc JL, Rascol O. Modafinil and pramipexole-associated somnolence. Mov Disord 2001; 16:783-784.
17. Hogl B, Saletu M, Brandauer E, Glatzl S, Frauscher B, Seppi K, Ulmer H, Wenning G, Poewe W. Modafinil for the treatment of daytime sleepiness in Parkinson’s disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial. Sleep 2002; 25:905-909.
18. Duteil J, Rambert FA, Pessonnier J, Gombert R, Assous E. A possible a-adrenergic mechanism for drug (CRL 40028)-induced hyperactivity. Eur J Pharmacol 1979; 121-123.
19. Rambert FA, Pessonnier J, de Sereville JE, Pointeau AM, Duteil J. Profil psychopharmacologique original de l’adrafinil chez la souris. J Pharmacol (Paris) 1986; 17:37-52.
20. Duteil J, Rambert FA., Pessonnier J., Hermant JF, Gombert R, Assous E. Central a-1-adrenergic stimulation in relation to the behaviour stimulating effect of modafinil: studies with experimental animals. Eur J Pharmacol 1990; 180:49-58.
21. Lin J, Roussel B, Akaoka H, Fort P, Debilly G, Jouvet M. Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat. Brain Res 1992; 591:19-26.
22. Lagarde D, Milhaud C. Electroencephalographic effects of modafinil, an a-1-adrenergic psychostimulant, on the sleep of rhesus monkey. Sleep 1990; 13:441-448.
23. Hermant JF, Rambert FA, Duteil J. Awakening properties of modafinil: effect on nocturnal acticity in monkeys (Macaca mulatta) after acute and repeated administration. Psychopharmacology 1991; 103:28-32.
24. Bastujji H, Jouvet M. Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil. Prog Neuro-Psychopharmacol & Biol Psychiat 1988; 12:695-700.
25. Billiard M, Besset A, Montplaisir J, Laffont F, Goldenberg F, Weill JS, Lubin S. Modafinil: a double blind multicentric study. Sleep 1994; 17:S107-S112.
26. Lin JS, Hou Y, Jouvet M. Potential brain neuronal targets for amphetamine-, methyphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat. Proc Natl Acad Sci USA. 1996; 93:14128-14133.
27. Scammell TE, Estabrooke IV, McCarthy MT, Chemelli RM, Yanagisawa M, Saper CB, Miller MS, Saper CB. Hypothalamic arousal regions are activated during modafinil-induced wakefulness. J Neurosci 2000; 20:8620-8628.
28. Mignot E, Nishino S, Guilleminault C, Dement WC. Modafinil binds to the dopamine uptake carrier site with low affinity. Sleep 1994; 17:436-437.
29. Dauvilliers Y, Neidhart E, Lecendreux M., Billiard M, Tafti M. MAO-A and COMT polymorphisms and gene effects in narcolepsy. Mol Psychiatry 2001; 6:367-372.
30. Dauvilliers Y, Neidhart E, Billiard M, Tafti M. Sexual dimorphism of the catecho-O-methyltransferase gene in narcolepsy is associated with response to modafinil. The Pharmacogenomics Journal 2002; 2:65-68